Colgate-Palmolive Company (CL)

From the record

Colgate-Palmolive Company's filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Colgate-Palmolive Company's 10 filed years say what it did: revenue went from $15 billion in fiscal 2016 to $20 billion in fiscal 2025, up 3.3% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Colgate-Palmolive Company's diluted share count shrank about 1.1% a year, and dividends and buybacks returned about 34% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 20 sales and 0 purchases of their own stock on the open market in the year to 2026-11-12 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Colgate-Palmolive Company earned about 3948 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 75 cents per dollar of everything the company owns. Leverage: it owed about 100 cents per dollar of assets, and net share issuance: its share count shrank 1.5% over the year (the filed statements).

From the record

Colgate-Palmolive Company's standing among 17 graded names in its industry family: revenue of $20 billion in fiscal 2025 ranks in the top 3% by size; a net margin of 10.5% ranks in the top 26%; revenue growth of 4.3% a year over the last 3 filed years ranks in the bottom 47% (its annual reports).

From the record

Colgate-Palmolive Company's leadership, from its insiders' filings and its current reports: the chief executive on the record is Wallace, Noel R. (Chairman, President & CEO, as filed), filing under that title since 2019-05-03, 7.5 years (top 39% of its family); the 19 officers and directors filing in the last fifteen months have been on the record a median of 6.7 years (top 39%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 19 people in charge now (top 14%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Colgate-Palmolive Company's room to grow, from the newest filed statements (fiscal 2025): cash of $1.3 billion against debt of $6.9 billion leaves -34.2% of its assets as net cash, bottom 3% of its family; cash from operations less capital spending is 17.8% of revenue (top 15%); a gross margin of 60.1% (bottom 38%); research spending of 1.8% of revenue (bottom 25%) (its annual report).

From the record

Colgate-Palmolive Company's growth drivers, from the filed years to fiscal 2025: revenue grew 4.3% a year over the last three filed years against 3.3% over all 10, speeding up (top 22% of its family); the newest year grew 1.4% (bottom 47%); research spending grew 4.6% a year (top 32%); capital spending grew -6.8% a year (bottom 28%) (its annual reports). Colgate-Palmolive Company reported 2 lines of business in fiscal 2025: Oral Personal and Home Care at $16 billion, Pet Nutrition at $4.6 billion. 2 of 2 grew in the latest filed year, and the largest line is 77% of revenue (its annual report).

From the record

Colgate-Palmolive Company's newest year against its own record: revenue of $20 billion in fiscal 2025 came in 4.1% below the $21 billion its prior three years' pace pointed to (bottom 41% of its family); net income of $2.1 billion against a prior three-year average of $2.3 billion (bottom 41%); a net margin of 10.5% against 12% before (bottom 34%) (its annual reports).